Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

docarpamine

Known as: N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine, do carpamine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The heart failure guideline in Japan has stated the necessity of investigating the role of oral inotropic agents in patients with… Expand
  • table I
  • table II
  • table III
  • table IV
Review
2009
Review
2009
  • Jung Min Lee, Kwang-Hyub Han, Sang Hoon Ahn
  • Journal of gastroenterology and hepatology
  • 2009
  • Corpus ID: 1583357
Ascites is the most common complication of liver cirrhosis, and it develops as a consequence of portal hypertension and… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND Salt-sensitive (SS) hypertension affects >30 million Americans and is often associated with low plasma renin activity… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2003
2003
Dopamine treatment constitutes a major advance towards the management of severe ovarian hyperstimulation syndrome (OHSS) by… Expand
Review
2002
Review
2002
  • S. Doggrell
  • Expert opinion on investigational drugs
  • 2002
  • Corpus ID: 29186197
In the periphery, physiological dopamine increases renal blood flow, decreases renal resistance and acts on the kidney tubule to… Expand
2000
2000
We studied the effects of bolus intravenous injection of the dopamine prodrug, docarpamine (200 μg/kg), on mean arterial pressure… Expand
1999
1999
OBJECTIVE:Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
1995
1995
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… Expand
1991
1991
Positive inotropic and renal vasodilatory effects of a novel dopamine prodrug, docarpamine, [N-(N-acetyl-L-methionyl)-3,4-bis… Expand
1990
1990
The metabolism of an orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and of… Expand